Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
17
×
national blog main
boston blog main
national top stories
biotech
boston top stories
san francisco blog main
san francisco top stories
gene therapy
new york blog main
new york top stories
clinical trials
deals
fda
national
novartis
san diego blog main
san diego top stories
san francisco
hemophilia
indiana blog main
indiana top stories
raleigh-durham blog main
spark therapeutics
startups
boston
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
raleigh-durham top stories
roche
seattle blog main
seattle top stories
texas blog main
texas top stories
vc
wisconsin blog main
wisconsin top stories
zolgensma
What
therapy
17
×
gene
drug
fda
approval
medicine
patients
therapeutics
bio
deal
roundup
advanced
approved
aren’t
car
crispr
cutting
developers
disease
edge
friday
healthcare
help
long
market
medicines
moves
new
oral
past
race
rna
roche
science
treat
won
access
address
age
agency
Language
unset
Current search:
therapy
×
" life sciences "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
FDA Official: New “Playbook” Needed for CMC Reviews of Gene Therapy Products
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Novome Lands $33M to Tweak a Gut Microbe Into a Metabolic Therapy
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
4 years ago
With Data, Pfizer/Sangamo Step Forward in Hemophilia Gene Therapy Race
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@xconomy.com
5 years ago
Virtual Physical Therapy Firms Reflexion and MindMaze Probe Markets
@xconomy.com
5 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed